Clinical Trials on Glabellar Crease

Total 10000 results

Université Catholique de Louvain

Recruiting

WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer (WinQ)

Breast Cancer

Belgium
Cancer Research Antwerp
Gasthuis Zusters Antwerpen; Ziekenhuis aan de Stroom; Iridium netwerk

Completed

Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer (ULTIMO)

Breast Cancer

Belgium
University Hospital Tuebingen

Completed

Retrospective Evaluation of Ultrasound-assisted Tumor Surgery in Breast-conserving Therapy (MAC004)

Breast Cancer

Germany
Damanhour University

Completed

Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy (Co-Pa-N)

Breast Cancer

Egypt
Chin-Tsung Shen
Ministry of Science and Technology, Taiwan

Completed

A Innovative Web-based Dance Movement Therapy

Breast Cancer

Taiwan
Ramsay Générale de Santé

Terminated

Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Breast Cancer

France
Institute of Oncology Ljubljana

Active, not recruiting

Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer (AKRA)

Breast Cancer

Slovenia
Shandong Suncadia Medicine Co., Ltd.

Completed

A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants

Breast Cancer

China
Fudan University

Active, not recruiting

Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

Breast Cancer

China
BeamWorks Inc.

Completed

Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound

Breast Cancer | Breast Neoplasms

South Korea
Zagazig University

Completed

Adjuvant Ultra-Hypofractionated vs Hypofractionated Radiotherapy for Early Breast Cancer (UHF vs HF-EBC)

Breast Cancer

Egypt
Novartis Pharmaceuticals

Completed

Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal (PORTRAIT)

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Genetics of Mammographic Appearances and Patterns (The GenMap Study)

Benign Breast Disease

United States
Atlas University

Not yet recruiting

Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer (ExoTSS-BC)

Breast Cancer | Invasive Breast Carcinoma | Pathological Complete Response | Exosomal microRNA | Neoadjuvant Chemotherapy Response
Criterium, Inc.

Recruiting

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Breast Cancer | Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer

United States
Shanghai Miracogen Inc.

Recruiting

A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients

Breast Cancer With Liver Metastases

China
Hospital Universitario San Ignacio
Pontificia Universidad Javeriana

Recruiting

Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer

Quality of Life | Breast Cancer | Tumor, Breast

Colombia
Cancer Registry of Norway

Recruiting

Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions (CABC)

Health, Subjective | Breast Cancer Patients

Norway
Institut Cancerologie de l'Ouest
Direction Générale de l'Offre de Soins

Recruiting

Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma (GANEA3)

Invasive Breast Cancer | Axillary Metastases

France
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Breast Cancer

United States
Wake Forest University Health Sciences
American Cancer Society, Inc.

Completed

REJOIN Trial for Older Breast Cancer Survivors (REJOIN)

Breast Cancer Female

United States
Mardin Artuklu University
The Scientific and Technological Research Council of Turkey

Active, not recruiting

A Quasi-Experimental Study to Improve Breast Cancer Awareness Among University Students (BCAwarenessUni)

Health Education | Early Detection of Cancer | Breast Cancer Awareness

Turkey
Pfizer

Completed

Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan

ER/PR(+), Her2(-) Breast Cancer

Taiwan
UNICANCER
Ministry of Health, France

Active, not recruiting

Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

Primary Non-metastatic Breast Cancer | Who Remain Disease-free

France
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer (NAC)

Stage 0/1 Breast Cancer | Post Biopsy | Pre-surgery

United States
Torbjorn Omland
Oslo University Hospital; Novartis; University Hospital of North Norway; Helse... and other collaborators

Completed

Prevention of Cardiac Dysfunction During Breast Cancer Therapy (PRADAII)

Heart Failure | Breast Cancer Female

Norway
Laekna Limited

Completed

PhI to Solid Tumors and PhII to Locally Advanced or mTNBC

Solid Tumor | TNBC - Triple-Negative Breast Cancer

China
Stemline Therapeutics, Inc.

Completed

Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast

United States
Syndax Pharmaceuticals

Completed

Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

Breast Cancer | Estrogen Receptor Positive Breast Cancer

United States
Swiss Group for Clinical Cancer Research

Completed

Trastuzumab & Pertuzumab Followed by T-DM1 in MBC

Metastatic Breast Cancer

France, Switzerland, Netherlands, Germany
Virginia Polytechnic Institute and State University
Carilion Clinic

Completed

Prospective Thinking in Hormone-Responsive Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast

United States
Nippon Kayaku Co., Ltd.

Completed

A Phase III Study of NK105 in Patients With Breast Cancer

Breast Cancer Nos Metastatic Recurrent

Japan
NYU Langone Health

Completed

Phase II Study for Solid Metastatic Tumors

Breast Cancer | Solid Tumor | Metastatic Breast Cancer
Cancer Trials Ireland

Terminated

The Myocet/Lapatinib Study. ICORG 10-03, V5

Her2 Positive Metastatic Breast Cancer

Ireland
Hoffmann-La Roche

Completed

A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate

Metastatic Breast Cancer

Hungary
Novartis Pharmaceuticals

Terminated

A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss

Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women

Germany
Pomeranian Medical University Szczecin
Maria Sklodowska-Curie National Research Institute of Oncology

Completed

Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients (Cisplatin)

Metastatic Breast Cancer | BRCA1 Mutation

Poland
AstraZeneca

Completed

Arthralgia During Anastrozole Therapy for Breast Cancer

Early Breast Cancer

France
Fujian Cancer Hospital

Recruiting

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Breast Neoplasms | Breast Diseases | Endocrine Breast Diseases | HR+/HER2- Breast Cancer | CDK4/6 Inhibitor | Dalpiciclib

China
British Columbia Cancer Agency

Not yet recruiting

SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors (SABR PRIMER)

Breast Cancer | Metastases

Canada
Yale University
Johns Hopkins University; Stemline Therapeutics, Inc.

Recruiting

Circulating Tumor DNA

ER+ Breast Cancer

United States
First Affiliated Hospital of Zhejiang University

Recruiting

Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)

HER2-positive Breast Cancer | Neoadjuvant Therapy | Pyrotinib

China
Yeon Hee Park

Not yet recruiting

Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer

Breast Cancer Metastatic
Institut Cancerologie de l'Ouest

Recruiting

To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer (DOMI-SOPHRO)

Breast Cancer Female

France
AstraZeneca

Recruiting

An Ophthalmic Safety Study in Patients With Breast Cancer

Ophthalmic Safety in Patients With Breast Cancer

Spain, Italy, France, Belgium, United States, Brazil, Portugal, Korea, Republic of, Poland, Argentina, Chile, Israel, Canada, Mexico
SciClone Pharmaceuticals

Recruiting

Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

Advanced Breast Cancer | Safety | ESR1 Gene Mutation

China
Xin-Wu Cui
Hubei Cancer Hospital; First Affiliated Hospital of Kunming Medical University and other collaborators

Recruiting

Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study

Breast Cancer Female

China
Min Yan, MD
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Breast Cancer Recurrent

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Aromatherapy in the Treatment of Early Breast Cancer

Early Breast Cancer

China
National University Hospital, Singapore

Not yet recruiting

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Other Solid Tumors | HER2+ Advanced Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations